Clinical Trial Update: A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 pharmacokinetic study to learn how the body processes Vepdegestrant in individuals with hepatic impairment; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• Vepdegestrant (ARV-471)

Snippet

Sponsor: Pfizer | Conditions: Healthy Participants | Phase 1 | Status: RECRUITING